EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The frequency of NUDT15 rs116855232 and its impact on mercaptopurine-induced toxicity in Syrian children with acute lymphoblastic leukemia

Muhammad Muhammad, Maher Saifo, Majd Aljamali, Mousa Alali, Khaled M Ghanem

Frontiers in Oncology · 18.03.2024 · 14

DOI: 10.3389/fonc.2024.1334846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 18.03.2024. Verfasst von Muhammad Muhammad und 4 weiteren Autor:innen. Beteiligte Einrichtung: BASMA Pediatric Oncology Unit, Damascus, Syria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Polymorphisms in NUDT15 may result in differences in mercaptopurine-induced toxicity. This study aimed to identify the frequency of the NUDT15 (c.415C>T; rs116855232) polymorphism and investigate the effect of this polymorphism on mercaptopurine-induced toxicity in a population of Syrian patients with childhood acute lymphoblastic leukemia (ALL).

Methods

This is a retrospective study that included children with ALL reaching at least 6 months of maintenance therapy. The NUDT15 genotyping was determined using standard targeted sequencing of polymerase chain reaction products. The odds ratio (OR) for the association between toxicity and genotype was evaluated.

Results

A total of 92 patients were enrolled. The majority of the patients in the study population were low-risk (63.04%), followed by intermediate-risk (25%), and high-risk (11.96%). There were 5 patients (5.4%) with NUDT15 (c.415C>T; rs116855232) CT genotype, and 1 patient (1.08%) with NUDT15 TT genotype, with allele frequencies of C=0.962 and T=0.038. The mercaptopurine median dose intensity was 100%, 54.69%, and 5% for the genotypes CC, CT, and TT, respectively ( P =0.009). Early onset leukopenia was significantly associated with the NUDT15 polymorphism (OR: 6.16, 95% CI: 1.11-34.18, P =0.037). There was no association between the NUDT15 genotype and hepatotoxicity.

Conclusion

Approximately 6.5% of the study population exhibited reduced NUDT15 activity. The mercaptopurine dose intensity was considerably low in NUDT15 rs116855232 TT genotype compared with CT and CC. The dosage of mercaptopurine should be adjusted according to the NUDT15 genotype in pediatric patients with ALL.

Schlagwörter

Stichwörter der Autor:innen

NUDT15Syriaacute lymphoblastic leukemiagenotypemercaptopurinepediatricpharmacogeneticstoxicity

Autor:innen und Institutionen

  • BASMA Pediatric Oncology Unit, Damascus, Syria.
  • Department of Oncology, Albairouni University Hospital, Faculty of Medicine, Damascus University, Damascus, Syria.
  • Faculty of Medicine, Damascus University, Damascus, Syria.
  • Department of Biochemistry and Microbiology, Faculty of Pharmacy, Damascus University, Damascus, Syria.
  • National Commission for Biotechnology (NCBT), Damascus, Syria.

Zitieren

APA

Muhammad, M., Saifo, M., Aljamali, M., Alali, M., & Ghanem, K. M. (2024). The frequency of NUDT15 rs116855232 and its impact on mercaptopurine-induced toxicity in Syrian children with acute lymphoblastic leukemia. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1334846

Vancouver

Muhammad M, Saifo M, Aljamali M, Alali M, Ghanem KM. The frequency of NUDT15 rs116855232 and its impact on mercaptopurine-induced toxicity in Syrian children with acute lymphoblastic leukemia. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1334846

BibTeX
@article{Muhammad2024,
  author = {Muhammad, Muhammad and Saifo, Maher and Aljamali, Majd and Alali, Mousa and Ghanem, Khaled M},
  title = {The frequency of NUDT15 rs116855232 and its impact on mercaptopurine-induced toxicity in Syrian children with acute lymphoblastic leukemia},
  journal = {Frontiers in Oncology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fonc.2024.1334846}
}
Kostenlos starten →